What we do Take Solutions Ltd delivers specialized software solutions and services in Life Sciences and Supply Chain Management, serving biopharma, automotive, and industrial clients globally. |
Founded in 2,000 |
Market share Significant presence in Life Sciences IT and niche Supply Chain sectors with global clientele including major biopharma firms. |
Problem solved Streamlines clinical trials, regulatory compliance in Life Sciences and optimizes supply chain processes for better tracking, compliance, and efficiency. |
Top clients or who we serve Innovator biopharma companies, generic manufacturers, automotive and industrial sectors; primarily B2B clients worldwide. |
Key management - |
Our journey and innovations Founded in 2000, expanded through acquisitions and product launches, introduced OneClinical eClinical platform and Green Check compliance software. |
Where we operate India, USA, Malaysia, Southeast Asia, and other international markets predominantly in Asia Pacific and Americas. |
Top products or what we offer OneClinical eClinical platform, PharmaReady software, and Supply Chain Management solutions across engineering and compliance verticals. |
Top brands OneClinical - leading eClinical platform with real-time data analytics; PharmaReady - Life sciences software; Green Check - compliance tool for supply chains. |
Raw materials needed - |
Raw materials supplier - |
Recurring vs cyclical contribution Revenue mostly from project-based and subscription services, with a mix of one-time and recurring contracts. |
Our industry position Emerging technology provider with niche focus; strong foothold in clinical and supply chain software domains. |
Financial highlights FY 2025 consolidated revenue approximately INR 102 million with profit of INR 7.38 million, showing recovery after prior losses. |
Geographical revenue split Revenue mainly from USA (over 80%), followed by Asia Pacific and Rest of World segments. |
Order book - |
Whats driving growth Investment in eClinical technology, global clinical trial demand, and regulatory compliance requirements drive growth. |
Our future plans Focus on diversifying operations, expanding partnerships and acquisitions in non-cash transactions to enter new verticals by FY 2026. |
Our green promise - |
Our people and values Committed to ethical governance despite operational challenges; investing in internal controls and employee engagement. |
Key challenges ahead Tax litigations, regulatory compliances, financial restructuring, and transitioning business focus amidst competitive markets. |
Interesting facts Successfully divested subsidiaries to stabilize finances; launched innovative compliance and clinical trial platforms enhancing market relevance. |
Risks and strategy Manages financial uncertainty through strategic divestments and aims growth via mergers and partnerships overcoming industry and operational risks. |
